Explore factors impacting RA and axSpA management, such as radiographic progression, and sex and gender differences.
Professor Lars Erik Kristensen is Head of Research at the Parker Institute in Copenhagen, Denmark, and holds an honorary doctoral position at Lund University, Sweden, and a professorship at Copenhagen University, Denmark. He received his medical degree from Copenhagen University and a PhD in Clinical Medicine from Lund University. He later specialised in internal medicine and rheumatology. Professor Kristensen also completed a postdoc at Karolinska University, Sweden.
Professor Kristensen’s research interests are degenerative and inflammatory arthritis, with a focus on patient value, lifestyle factors, treatment response and predictors thereof in randomised controlled trials and observational settings. He also managed his own research group (South Swedish Arthritis Treatment Group [SSATG]) in Lund from 2011 to 2013. Professor Kristensen is also a board member and head of research at the Danish Society of Rheumatology. He has given >250 lectures at national and international congresses and meetings.
Explore factors impacting RA and axSpA management, such as radiographic progression, and sex and gender differences.
Integrating holistic care through guideline recommendations with patient-reported outcomes and shared decision-making
Personalised HS care: Addressing the multi-faceted burden of HS with a case study example
The role of combined medical/surgical and medical-only treatments, including the optimal time for intervention
Key guideline updates including management algorithms for inflammatory and non-inflammatory HS phenotypes
Prof. Prignano and Prof. Liakou discuss patient-reported outcomes, shared decision-making and multidisciplinary HS care